For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Sonopet Ultrasonic Aspirator | Treatment of VIN dysplasia with sonopet ultrasonic aspirator: to evaluate the incident of recurrence of VIN dysplasia events in women treated for VIN with the sonopet ultrasonic aspirator compared to CO2 Laser Ablation Sonopet Ultrasonic Aspirator: To evaluate the incident of recurrence of VIN dysplasia events in women treated for VIN with the sonopet ultrasonic aspirator compared to CO2 Laser Ablation | 0 | None | 0 | 19 | 12 | 19 | View |
| CO2 Laser Ablation | Treatment of VIN dysplasia with CO2 Laser Ablation: to evaluate the incident of recurrence of VIN dysplasia events in women treated for VIN with the sonopet ultrasonic aspirator compared to CO2 Laser Ablation CO2 Laser Ablation: To evaluate the incident of recurrence of VIN dysplasia events in women treated for VIN with the sonopet ultrasonic aspirator compared to CO2 Laser Ablation | 0 | None | 0 | 28 | 18 | 28 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| cellulitis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| discomfort | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| vaginal bleeding | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| discharge | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| anal pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| tenderness | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| irritation | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| yeast infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| itching | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| soreness at site | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |